STEMCELL Technologies Inc.
The B.C. Tech Association recognized STEMCELL Technologies Inc. as the Company of the Year at its annual Technology Impact Awards (TIA) held this month.…
The B.C. Tech Association recognized STEMCELL Technologies Inc. as the Company of the Year at its annual Technology Impact Awards (TIA) held this month.
STEMCELL Technologies is one of Canada’s largest biotech firms and develops stem cell tools for researchers across the world. The company currently employs close to 1,000 people worldwide and saw its revenue grow 20% in 2016 according to an article posted by Business Vancouver.
Accepting the award, Dr. Allen Eaves, President and CEO, STEMCELL Technologies Inc. said “We want to be the company that is going to help support our health care system, [and] get it out of the terrible mess it’s in by providing new and wonderful tools that we will sell to the rest of the world,” as quoted by betakit.com.
We’ve written about Dr. Eaves previously on this site and his dedication to eradicating cancer.
Founded in 1994, the TIAs celebrate BC’s leaders and rising stars in the innovation and technology sectors. According to the Association, the technology sector in BC delivers nearly $25 billion in revenue and has been one of the strongest contributors to BC’s economic growth over the past decade employing over 90,000 people across 9,000 companies.
Dr. Allen Eaves, President and CEO of STEMCELL Technologies Inc., has been awarded Entrepreneur of the Year Pacific Winner by Ernst and Young Canada.…
Dr. Allen Eaves, President and CEO of STEMCELL Technologies Inc., has been awarded Entrepreneur of the Year Pacific Winner by Ernst and Young Canada.
The theme for the 2016 awards is recognizing accelerators — those entrepreneurs who “accelerate all of us by bringing us new products and services and by driving our economy” explains Lui Pettrollini, Entrepreneur of the Year Pacific Program Director, in an article carried in the Globe & Mail’s Report On Business Magazine.
Dr. Eaves founded STEMCELL in 1993 to support his own research as the head of the BC Cancer Agency’s Terry Fox Laboratory in Vancouver. Unable to source what he needed to support his research, Dr. Eaves began making media for growing blood-forming stem cells. Today, STEMCELL Technologies offers more than 2,000 cell biology tools to researchers in over 80 countries. It is Canada’s largest biotech company with 850 employees and $150 million in annual sales.
“I run my company like a graduate training program,” Dr. Eaves said in the ROB Magazine piece. “Scientists have a lot of freedom in deciding what they can work on and that inspires them to be creative and think clever thoughts.”
Dr. Eaves has also developed a group of companies including STEMSOFT Software Inc., that makes software for managing data in bone marrow centres, cord blood banks, cellular therapy companies as well as tumour and tissue repositories. He also founded Malachite Management Inc., which provides association management, conference management, fundraising and strategic planning to medical and scientific organizations.
Dr. Eaves is a major supporter of the Canadian Stem Cell Foundation as both a member of the Board of Directors and a founding Till & McCulloch Leadership Circle member.
Dr. Eaves’ accomplishments will be celebrated along with other regional winners on November 22nd at the EY National Awards Gala in Toronto.
Dr. Allen Eaves, a member of the Canadian Stem Cell Foundation’s Board of Directors and a founding Till & McCulloch Leadership Circle member, is being appointed to the Order of British Columbia — the province’s highest form of recognition.…
Dr. Allen Eaves, a member of the Canadian Stem Cell Foundation’s Board of Directors and a founding Till & McCulloch Leadership Circle member, is being appointed to the Order of British Columbia — the province’s highest form of recognition.
An internationally respected leukemia researcher and clinician, Dr. Eaves is the founder and owner of Vancouver’s STEMCELL Technologies Inc., Canada’s largest biotech company. He co-founded the Terry Fox Laboratory and served as its director for 25 years as well as heading the BC Cancer Agency for 18 years, developing one of the first bone marrow transplant programs in the world.
Called the “cell-made man” by BC media, Dr. Eaves began STEMCELL in 1993 with a staff of eight. He now employs more than 800 people. STEMCELL develops specialty cell culture media, cell separation products and ancillary reagents for life science research and delivers them to scientists around the world. In 2015 STEMCELL was named Life Sciences Company of the Year by LifeSciences BC.
Dr. Eaves has a strong incentive to continue his efforts, telling BCBusiness in 2013 that “I want t to cure cancer. That’s the motivation,” he said. “It’s all about curing some of these diseases, wiping them off the face of the earth.”
The investiture will take place July 26 in Victoria. To read more about Dr. Eaves, click here.
STEMCELL Technologies, the largest biotech company in Canada, will be honoured tonight with the “Life Sciences Company of the Year” award from LifeSciences BC.…
STEMCELL Technologies, the largest biotech company in Canada, will be honoured tonight with the “Life Sciences Company of the Year” award from LifeSciences BC.
Founded in 1993 by Dr. Allen Eaves, a Canadian Stem Cell Foundation Director, STEMCELL Technologies is a privately owned biotechnology company that develops specialty cell culture media, cell separation products and ancillary reagents for life science research. The Vancouver-based firm employs some 680 people who manufacture over 2,000 products for scientists in more than 70 countries worldwide.
Each year, a significant portion of STEMCELL’s profits is reinvested in stem cell research — a strong indication of its founder’s belief in the potential of the field.
“Stem cell technology is going to revolutionize medicine; that’s the reality,” says Dr. Eaves, President & CEO. “Medicine will be delivered by cells and we will be using cells to repair the body. There is this huge potential out there.” Click here to read our full interview with Dr. Eaves.
He also believes that to succeed in delivering new stem treatments, Canada needs the Canadian Stem Cell Strategy & Action Plan. Created by a coalition of scientists, medical doctors, leaders from major health charities, industry experts and philanthropists, the Strategy sets the course for Canada to lead the way in bringing up to 10 breakthrough therapies to the clinic by 2025.